These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 36631159

  • 1. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
    Esen I, Arends S, Dalsgaard Nielsen B, Therkildsen P, Hansen I, van 't Ende A, Heeringa P, Boots A, Hauge E, Brouwer E, van Sleen Y.
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36631159
    [Abstract] [Full Text] [Related]

  • 2. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [Abstract] [Full Text] [Related]

  • 3. Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica.
    Low C, Conway R.
    Womens Health (Lond); 2023 Apr; 19():17455057221147385. PubMed ID: 36627860
    [Abstract] [Full Text] [Related]

  • 4. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
    van Sleen Y, Graver JC, Abdulahad WH, van der Geest KSM, Boots AMH, Sandovici M, Brouwer E.
    Front Immunol; 2019 Apr; 10():1981. PubMed ID: 31507597
    [Abstract] [Full Text] [Related]

  • 5. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F, Dejaco C, Matteson EL, Dasgupta B.
    JAMA; 2016 Jun 14; 315(22):2442-58. PubMed ID: 27299619
    [Abstract] [Full Text] [Related]

  • 6. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
    Borresen SW, Thorgrimsen TB, Jensen B, Hilsted L, Bartels EM, Feldt-Rasmussen U, Locht H.
    Rheumatology (Oxford); 2020 Oct 01; 59(10):2764-2773. PubMed ID: 32031663
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
    Barde F, Ascione S, Pacoureau L, Macdonald C, Salliot C, Boutron-Ruault MC, Seror R, Nguyen Y.
    Semin Arthritis Rheum; 2024 Feb 01; 64():152298. PubMed ID: 38000317
    [Abstract] [Full Text] [Related]

  • 8. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J, Warrington KJ.
    Drugs Aging; 2011 Aug 01; 28(8):651-66. PubMed ID: 21812500
    [Abstract] [Full Text] [Related]

  • 9. Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
    Manning JE, Harris E, Mathieson H, Sorensen L, Luqmani R, McGettrick HM, Morgan AW, Young SP, Mackie SL.
    J Autoimmun; 2024 Jul 01; 147():103260. PubMed ID: 38797046
    [Abstract] [Full Text] [Related]

  • 10. [Polymyalgia rheumatica and temporal arteritis].
    Vos PA, Bijlsma JW, Derksen RH.
    Ned Tijdschr Geneeskd; 2005 Aug 27; 149(35):1932-7. PubMed ID: 16159030
    [Abstract] [Full Text] [Related]

  • 11. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
    Paskins Z, Whittle R, Sultan AA, Muller S, Blagojevic-Bucknall M, Helliwell T, Hider S, Roddy E, Mallen C.
    BMC Med; 2018 Jan 10; 16(1):4. PubMed ID: 29316928
    [Abstract] [Full Text] [Related]

  • 12. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
    Salvarani C, Padoan R, Iorio L, Tomelleri A, Terrier B, Muratore F, Dasgupta B.
    Autoimmun Rev; 2024 Jan 10; 23(1):103415. PubMed ID: 37625672
    [Abstract] [Full Text] [Related]

  • 13. Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study.
    Moreel L, Betrains A, Boeckxstaens L, Molenberghs G, Van Laere K, De Langhe E, Vanderschueren S, Blockmans D.
    Semin Arthritis Rheum; 2024 Oct 10; 68():152499. PubMed ID: 38968729
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides-Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort.
    Palmowski A, Wiebe E, Muche B, Hermann S, Dejaco C, Matteson EL, Buttgereit F.
    Cells; 2022 Feb 04; 11(3):. PubMed ID: 35159345
    [Abstract] [Full Text] [Related]

  • 15. Clinical features of polymyalgia rheumatica and giant cell arteritis.
    Salvarani C, Pipitone N, Versari A, Hunder GG.
    Nat Rev Rheumatol; 2012 Sep 04; 8(9):509-21. PubMed ID: 22825731
    [Abstract] [Full Text] [Related]

  • 16. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M.
    Rheumatology (Oxford); 2003 Sep 04; 42(9):1055-61. PubMed ID: 12730520
    [Abstract] [Full Text] [Related]

  • 17. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
    Emamifar A, Hess S, Gerke O, Hermann AP, Laustrup H, Hansen PS, Thye-Rønn P, Marcussen N, Svendstrup F, Gildberg-Mortensen R, Bang JC, Farahani ZA, Chrysidis S, Toftegaard P, Andreasen RA, le Greves S, Andersen HR, Olsen RN, Hansen IMJ.
    Medicine (Baltimore); 2017 Jun 04; 96(26):e7297. PubMed ID: 28658131
    [Abstract] [Full Text] [Related]

  • 18. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
    De Miguel E, Karalilova R, Macchioni P, Ponte C, Conticini E, Cowley S, Tomelleri A, Monti S, Monjo I, Batalov Z, Klinowski G, Falsetti P, Kane DJ, Campochiaro C, Hočevar A.
    Ann Rheum Dis; 2024 Feb 15; 83(3):335-341. PubMed ID: 37932008
    [Abstract] [Full Text] [Related]

  • 19. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    Liozon E, de Boysson H, Dalmay F, Gondran G, Bezanahary H, Fauchais AL, Ly KH.
    J Rheumatol; 2018 May 15; 45(5):678-685. PubMed ID: 29545449
    [Abstract] [Full Text] [Related]

  • 20. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
    Vieira M, Comarmond C, Labreuche J, Mirouse A, Saadoun D, Richez C, Flipo RM, Hachulla E, Drumez E, Cacoub P, FAIR/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors.
    J Autoimmun; 2022 Oct 15; 132():102868. PubMed ID: 35926375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.